Exam (elaborations)
ADVANCED PHARMACOLOGY FOR PRESCRIBERS 1ST EDITION BY LUO KAYINGO TEST BANK | 2024 UPDATE
ADVANCED PHARMACOLOGY FOR PRESCRIBERS 1ST EDITION BY LUO KAYINGO TEST BANK | 2024 UPDATE
[Show more]
Connected book
Book Title:
Author(s):
- Edition:
- ISBN:
- Edition:
Content preview
ADVANCED PHARMACOLOGY FORPRESCRIBERS 1ST EDITION BY LUO
KAYINGO TEST BANK | 2024 UPDATE
, Table of Contents
V V
Chapter V 1: V An VIntroduction Vto VEvidence-Based VClinical V Practice VGuidelines ...................................... 3
Chapter V 2: VPharmacokinetics V /Chapter3: VPharmacodynamics............................................................... 13
Chapter4: VPharmacogenetics V and VPharmacogenomics .......................................................................... 25
Chapter V 5: VPharmacology V Across V the VLife VSpan................................................................................. 30
Chapter V 6: VDrug-Therapy VPrescribing Vin VSpecial VPopulations ............................................................. 36
Chapter V 7: VDrug VDevelopment V and VApproval ..................................................................................... 45
Chapter V8-Chapter V10: VFoundations Vof VPrescription VWriting VChapter V9: VResponsibleControlled-
Substance VPrescribing VChapter V10: VAntibiotic VStewardship .................................................................. 51
Chapter V 11: V Applied VCalculations V for V Prescribing .............................................................................. 58
Chapter V12-: VPromoting VAdherence VWith VPharmacotherapy VII: VSystem-Specific Vand VPatient-Focused
VPrescribing VChapter V13: VPharmacotherapy Vfor VEar, VNose, VMouth, VandThroat VConditions V/Chapter V14:
VPharmacotherapy Vfor V Eye VConditions .................................................................................................. 67
Chapter V 15: VPharmacotherapy Vfor V Skin VConditions ............................................................................. 74
Chapter V 16: VPharmacotherapy V for V Neurologic V Conditions .................................................................. 81
Chapter V 17: VPharmacotherapy Vfor V Cardiovascular V Conditions ............................................................ 94
Chapter V 18: VPharmacotherapy Vfor V Respiratory VConditions ................................................................ 106
Chapter V19: VPharmacotherapy Vfor VGastrointestinal VConditions Vand VConditions VRequiringNutritional
VSupport ............................................................................................................................................... 117
Chapter V 20: VPharmacotherapy V for V Genitourinary VConditions ............................................................ 128
Chapter V21: VPharmacotherapy Vfor V Renal, V Acid–Base, V Fluid, Vand VElectrolyte VDisorders.................. 133
Chapter V 22: VPharmacotherapy Vfor V Musculoskeletal Vand VRheumatologic V Conditions ........................ 146
Chapter V 23: VTherapeutic V Applications V of VImmunology Vand V Vaccines ............................................. 158
Chapter V 24: VPharmacotherapy V for V Endocrine VDisorders .................................................................... 163
Chapter V25: VPharmacotherapy Vfor VHematologic V Disorders ................................................................ 174
Chapter V 26: VHematology/Oncology Vand VSupportive V Care Vfor V the VNononcologist............................. 190
Chapter V 27: VPharmacotherapy V Related Vto VWomen’s V Health VConditions .......................................... 196
Chapter V 28: VPharmacotherapy VRelated Vto VMen’s V Health V Conditions ................................................ 211
Chapter V 29: VPharmacotherapy V Related Vto VTransgender V Care............................................................ 217
Chapter V 30: VAntimicrobial VPharmacotherapy...................................................................................... 224
Chapter V 31: V Antiretroviral VPharmacotherapy ...................................................................................... 235
Chapter V32: VPsychopharmacology Vand VIntegrative VHealth: VCombined VTreatment VofPsychiatric Vand
VNeurocognitive V Conditions ................................................................................................................. 247
Chapter V 33: VPharmacotherapy Vfor V Pain VManagement ........................................................................ 257
Chapter V 34: VSubstance V Use VDisorder V III: VHealth VPromotion Vand VMaintenance ................................ 267
Chapter V 35: VOver-the-Counter V Medications........................................................................................ 283
Chapter V36: VPharmacotherapy Vfor V Obesity......................................................................................... 291
, Chapter V1: VAn VIntroduction V to VEvidence-Based VClinical VPractice VGuidelines
MULTIPLE VCHOICE
• What Vis Vthe Vprimary Vpurpose V of Vthe V nursing V assessment?
A. Identifying V underlying V pathologic V conditions
B. Assisting V the V physician V in Videntifying V medical V conditions
C. Determining V the Vpatients Vmental Vstatus
D. Exploring V patient V responses V to V health V problems
ANS: VD
A Vnursing Vassessment Vis Vdone Vto Videntify Vthe Vpatients Vresponse Vto
Vhealth Vproblems. VDuring Vthe V nursing Vassessment Vphase, V a
Vcomprehensive V information Vbase V is Vdeveloped V through Va Vphysical
Vexamination, V nursing V history, V medication V history, V and Vprofessional
Vobservation. V Identifying Vunderlying Vpathologic Vconditions Vand Vassisting
Vthe Vphysician V in V identifying Vmedical Vconditions V is Vnot Vpart V of V the
Vnursing Vprocess. VDetermining V the Vpatients V mental Vstatus V is Vone Vpart
V of Vthe V nursing V assessment, V but V it V is V not Vthe Vprimary Vpurpose.
DIF: VCognitive VLevel:
VComprehension VREF: Vdm V36 VOBJ: V1
V | V3 VTOP: VNursing VProcess VStep:
VAssessment
MSC: VNCLEX V Client VNeeds V Category: V Health VPromotion V and V Maintenance
• What Vis Vthe Vbasis V of Vthe VNANDA VI V taxonomy?
A. Functional V health Vpatterns
B. Human Vresponse V patterns
C. Basic V human V needs
D. Pathophysiologic V needs
ANS: VB
The V NANDA V I V taxonomy V identifies V human V response V patterns.
VFunctional V components V of V health Vpatterns Vare V limited Vto V activity, V fluid
Vvolume, V nutrition, Vself Vcare, V and Vsensory Vperception. VBasic V human
Vneeds Vcomprise V less Vthan Vmerely V health Vpatterns. V Pathophysiologic
Vneeds V are V not Vpart V of Vthe Vscope V of VNANDA VI.
, DIF: VCognitive VLevel: VKnowledge
VREF: Vpp. V37-38 VOBJ: V5 VTOP:
Nursing VProcess VStep: VDiagnosis
MSC: VNCLEX V Client V Needs V Category: VPhysiological V Integrity
• Which Vtask V is Vincluded V in Vthe V assessment Vstep V of Vthe V nursing V process?
A. Establishing V patient V goals/outcomes
B. Implementing V the V nursing Vcare V plan V (NCP)
C. Measuring V goal/outcome V achievement
D. Collecting V and V communicating V data
ANS: VD
Data Vare Vcollected Vand Vcommunicated Vin Vthe Vassessment Vphase Vof Vthe
Vnursing Vprocess. VEstablishing Vgoals V is Vthe V function V of Vplanning.
Implementing Vthe VNCP Vis Vthe Vfunction Vof Vimplementation. VMeasuring
Voutcome V achievement V is Vthe V function V of Vevaluation.
DIF: VCognitive VLevel:
VComprehension VREF: Vdm V36 VOBJ: V2
V | V3 VTOP: VNursing VProcess VStep:
VAssessment
MSC: VNCLEX V Client VNeeds V Category: V Health VPromotion V and V Maintenance
• Which Vstatement V regarding V nursing V diagnoses V is V accurate?
a. Nursing Vdiagnoses Vremain Vthe Vsame V for Vas V long Vas Vthe Vdisease V is V present.
b. Nursing V diagnoses V are Vwritten V to V identify Vdisease Vstates.
c. Nursing V diagnoses Vdescribe V patient Vproblems Vthat V nurses V treat.
d. Nursing Vdiagnoses V identify Vcauses V related Vto V illness.
ANS: VC
Diagnostic Vstatements Videntify Vproblems Va Vnurse Vis Vindependently Vable
Vto Vtreat Vwithin Vthe Vscope V of Vprofessional Vpractice. VNursing Vdiagnoses
Vvary Vwith Vthe Vchanging V condition V of Vthe Vpatient. V The Vresponse
Vpatterns Vare Vunique V to Vthe Vpatient V and Vare V not Vdisease Vspecific.
VNursing Vdiagnoses Vdescribe Vthe Vpatients V human Vresponse Vpattern.
DIF: V Cognitive V Level: V Comprehension
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Ascorers. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $16.49. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
72042 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now
